FDA Inspection
Fareva PauFareva Pau – FDA Inspection, Nov 5, 2021
Record Details
This FDA Inspection record concerns Fareva Pau, with an inspection on November 5, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fareva Pau
- Inspection Date
- November 5, 2021
- Product Type
- Drugs
View Company Profile
ID · ed1afa6d-268f-47df-b20c-332836554f3d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202791
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fareva Pau
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2019 | Not classified | Office of Inspections and Investigations | |
| April 27, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fareva Pau
- FDA Inspection 1101981 - 2019-09-10
- FDA Inspection 1100335 - 2018-04-27
- FDA Inspection 1020864 - 2017-04-13
- FDA Inspection 946909 - 2015-06-10
- FDA Inspection 821739 - 2013-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.